ABSTRACT
Introduction: Cystoscopic intraluminal placement of ureteral stents has become a routine practice in urology. Ureteral stents preserve urine flow from the kidney to the bladder in cases of ureteral obstruction [intrinsic or extrinsic]. In patients with obvious ureteral obstruction, the placement of a ureteral stent will restart urine transport and protect the kidney from possible risks. Ureteral stents are troublesome in some patients and causes LUTS. Study Design: Prospective randomized controlled trial. Setting: Urology Department, Sheikh Zayed Hospital Lahore. Period: Six month started from August 2015 to December 2015
Material and Methods: 100 patients who were randomly divided into two equal groups. The patients were between 18 to 50 years of age of both gender undergo retrograde double-J ureteral stent placement. Before the double-J stent will be applied, all patients completed an International Prostate Symptom Score [IPSS] questionnaire for evaluation of lower urinary tract symptoms. Patients were divided in two groups on the basis of lottery method tamsolusin group [1] and placebo group [2]. Tamsulosin group patients was given tamsulosin post operatively and placebo group was given a placebo postoperatively
Results: There were total 100 patients who were enrolled in this study with a mean age of 42.63 +/- 6.24. There were 75[75%] were male while 25[25%] were female. The mean IPSS sore at presentation was 2.47 +/- 1.43 and post treatment was 5.20 +/- 1.65. There was significant difference in IPSS score in control group with mean 5.28 +/- 1.69 versus study as mean 2.22 +/- 1.05 group, p-value= 0.010
Conclusion: There is difference in lowering of IPSS score in the patients who are given tamsolusin versus those who were retained on placebo